Table 3.
Open‐eye state at night during baseline, DBS‐ON, CO‐ON and CO‐OFF phases (the first period of the crossover phase is highlighted in gray); values are expressed in number of observations (out of number of assessments; and percentage)
| Patient | Baseline | DBS‐ON | CO‐ON | CO‐OFF |
|---|---|---|---|---|
| P1 | 1 (14; 7.1%) | 6 (25; 24%) | 4 (14; 28.6%) | 2 (10; 20%) |
| P2 | 6 (24; 25%) | 1 (38; 2.6%)a | 2 (8; 25%) | 0 (9; 0%) |
| P3 | 11 (16; 68.8%) | 1 (40; 2.5%)a | 1 (6; 16.7%)a | 2 (13; 15.4%)a |
| P4 | 2 (14; 14.3%) | 3 (22; 13.6%) | 3 (13; 23.1%) | 3 (6; 50%) |
| P5 | n.a. | |||
| All ‐ P5 | 20 (68; 29.4%) | 11 (125; 8.8%)a | 10 (41; 24.4%) | 7 (38; 18.4%) |
a
Significant difference (P < 0.05) with baseline.